Zymeworks Appoints Oleg Nodelman to Board of Directors

Zymeworks Inc. has announced the appointment of Oleg Nodelman to its Board of Directors, effective February 17, 2025. As the Founder and Managing Director of EcoR1 Capital, LLC, a biotech-focused investment firm, Mr. Nodelman brings over two decades of experience in investment management, business development, and biotech strategy. His addition marks the seventh new board appointment in Zymeworks' ongoing board renewal process.

“As the largest current stockholder of Zymeworks, we at EcoR1 are aligned with the company’s mission and long-term vision,” said Mr. Nodelman. Zymeworks CEO Kenneth Galbraith highlighted his extensive industry expertise as a key asset in advancing the company’s pipeline of novel biotherapeutics.

With a strong track record in biotech investments and current board roles at Galapagos NV and AnaptysBio, Mr. Nodelman’s appointment strengthens Zymeworks' commitment to delivering transformative therapies and driving lasting value for patients and stockholders.